Cleared Traditional

K820336 - DAKO PAP KIT K509

K820336 is an FDA 510(k) clearance for DAKO PAP KIT K509, manufactured by Dako Corp.. The device is a Class 1 Pathology device with product code LIJ cleared through the Traditional 510(k) pathway after a 155-day FDA review.

K820336 · Dako Corp. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1982
Decision
155d
Days
Class 1
Risk

K820336 is an FDA 510(k) clearance for the DAKO PAP KIT K509. Classified as Peroxidase Anti-peroxidase Immunohistochemical Stain (product code LIJ), Class I - General Controls.

Submitted by Dako Corp. (Mchenry, US). The FDA issued a Cleared decision on July 13, 1982 after a review of 155 days - an extended review cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.4400 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Pathology review framework, consistent with the majority of Class II 510(k) submissions.

View all Dako Corp. devices

FDA 510(k) Submission Details - K820336

510(k) Number K820336 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 08, 1982
Decision Date July 13, 1982
Days to Decision 155 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d slower than avg
Panel avg: 77d · This submission: 155d
Pathway characteristics
Predicate-based equivalence.

LIJ Device Classification - Class 1, General Controls

Product Code LIJ Peroxidase Anti-peroxidase Immunohistochemical Stain
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.4400
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.